Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Gallagher CindyCAO | Option exercise | M | — 9,592 sh | Aug 7, 2026 |
| 21 | Buckley Sean PatrickSee Remarks | Open-market sale · 10b5-1 plan | SELL | $442K 19.2K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 21 | Quinton SashaEVP, Pres. CBG | Option exercise | M | — 20.5K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 21 | Gosser TrishaCFO | Option exercise | M | — 29.6K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 21 | Paquette AnthonyChief Financial Officer | Option exercise | M | — 75.0K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 21 | Stat Lauren Elaina FriedmanDirector | Open-market sale · 10b5-1 plan | SELL | $500K 3,032 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 21 | Lazar David E.Director, Chief Executive Officer, 10% Owner | Derivative conversion | C | $81.00M 9.00M sh | Aug 7, 2026 traded Aug 5, 2026 |
| 20 | Walsh Mark T.Director, CEO & Director | Open-market sale · 10b5-1 plan | SELL | $152K 13.1K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 20 | Walsh Mark T.Director, CEO & Director | Open-market sale · 10b5-1 plan | SELL | $152K 13.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 19 | Chesley PhilipSVP, High Performance Analog | Tax withholding | F | $285K 2,999 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 19 | Paquette AnthonyChief Financial Officer | Option exercise | M | $883K 75.0K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 19 | Lee Kam Yee SusannaDirector | Grant or award | A | — 42.6K sh | Aug 7, 2026 traded Jul 31, 2026 |
| 19 | Syz Marc Oliver ChristopherDirector | Grant or award | A | — 42.6K sh | Aug 7, 2026 traded Jul 31, 2026 |
| 19 | Rogers Alfred Tate JrDirector, CEO & President | Derivative conversion | C | — 242 sh | Aug 7, 2026 traded Jul 14, 2026 |
| 19 | Manfredi ManuelChief Financial Officer | Option exercise | M | — 79.3K sh | Aug 7, 2026 traded Jul 30, 2026 |
| 19 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $4.37M 71.5K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 19 | Rogers Alfred Tate JrDirector, CEO & President | Derivative conversion | C | — 52 sh | Aug 7, 2026 traded Jul 14, 2026 |
| 19 | Brown GrantSVP & Chief Financial Officer | Tax withholding | F | $440K 4,628 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 19 | Chan Kin KennethDirector | Grant or award | A | — 42.6K sh | Aug 7, 2026 traded Jul 31, 2026 |
| 19 | Rogers Alfred Tate JrDirector, CEO & President | Derivative conversion | C | — 8 sh | Aug 7, 2026 traded Jul 14, 2026 |
| 19 | Wang Daniel Hua-changDirector | Grant or award | A | — 42.6K sh | Aug 7, 2026 traded Jul 31, 2026 |
| 19 | Rogers Alfred Tate JrDirector, CEO & President | Derivative conversion | C | — 98 sh | Aug 7, 2026 traded Jul 14, 2026 |
| 18 | Buonasera DavidCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $95K 4,176 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 18 | Thomson Matthew ChristopherHead of Revenue | Open-market sale · 10b5-1 plan | SELL | $30K 15.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 18 | Buonasera DavidCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $62K 2,602 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 17 | Kennedy PatrickDirector | Grant or award | A | — 1,605 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 17 | Newinski Laura MarieDirector | NABrookfield Private Equity Fund LP Grant or award | A | — 1,358 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 17 | Maher Michael WCFO & Treasurer | Option exercise · 10b5-1 plan | M | $318K 44.7K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 17 | Maher Michael WCFO & Treasurer | Option exercise · 10b5-1 plan | M | $318K 44.7K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 17 | Ledbetter Samuel CraigSVP Chief Supply Chain Officer | Grant or award | A | — 2,404 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 17 | Quinton SashaEVP, Pres. CBG | Option exercise | M | — 7,549 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 17 | Saunders Brent LDirector, Chairman of the Board and CEO | Grant or award | A | — 281.9K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 17 | Gosser TrishaCFO | Option exercise | M | — 29.6K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 16 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $807K 12.1K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 16 | Ditillo DavidChief Information Officer | Open-market sale · 10b5-1 plan | SELL | $422K 12.4K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 16 | Gosser TrishaCFO | Tax withholding | F | $82K 9,465 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $75K 10.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 16 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $632K 9,803 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 16 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $406K 6,006 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $2.37M 18.3K sh | Aug 7, 2026 traded Aug 6, 2026 |